A family of protein-deglutamylating enzymes associated with neurodegeneration

Rogowski, K.; van Dijk, J.; Magiera, M. M.; Bosc, C.; Deloulme, J. C.; Bosson, A.; Peris, L.; Gold, N. D.; Lacroix, B.; Grau, M. B.; Bec, N.; Larroque, C.; Desagher, S.; Holzer, M.; Andrieux, A.; Moutin, M. J.; Janke, C.


2010-11-12 / vol 143 / pages 564-78


Polyglutamylation is a posttranslational modification that generates glutamate side chains on tubulins and other proteins. Although this modification has been shown to be reversible, little is known about the enzymes catalyzing deglutamylation. Here we describe the enzymatic mechanism of protein deglutamylation by members of the cytosolic carboxypeptidase (CCP) family. Three enzymes (CCP1, CCP4, and CCP6) catalyze the shortening of polyglutamate chains and a fourth (CCP5) specifically removes the branching point glutamates. In addition, CCP1, CCP4, and CCP6 also remove gene-encoded glutamates from the carboxyl termini of proteins. Accordingly, we show that these enzymes convert detyrosinated tubulin into Delta2-tubulin and also modify other substrates, including myosin light chain kinase 1. We further analyze Purkinje cell degeneration (pcd) mice that lack functional CCP1 and show that microtubule hyperglutamylation is directly linked to neurodegeneration. Taken together, our results reveal that controlling the length of the polyglutamate side chains on tubulin is critical for neuronal survival.

Read on PubMed

S0092-8674(10)01184-0 [pii] 10.1016/j.cell.2010.10.014

1097-4172 (Electronic) 0092-8674 (Linking)

IGMM team(s) involved in this publication

Humans; Animals; Mice; Amino Acid Sequence; Molecular Sequence Data; Cell Line; Cell Survival; Sequence Alignment; Carboxypeptidases/*metabolism; Cerebellum/pathology; GTP-Binding Proteins/*metabolism; Mice, Inbred BALB C; Nerve Degeneration/*metabolism; Olfactory Bulb/pathology; Polyglutamic Acid/*metabolism; Serine-Type D-Ala-D-Ala Carboxypeptidase/*metabolism; Tubulin/metabolism

Back to all publications